|
Prasugrel Impurity M
|
普拉格雷雜質(zhì)M
|
1443034-67-0
|
|
Terbutaline Impurity 38
|
特布他林雜質(zhì)38
|
30923-82-1
|
|
Terbutaline Impurity 21
|
特布他林雜質(zhì)21
|
28924-20-1
|
|
1-[2,5-bis(benzyloxy)phenyl]ethan-1-one
|
2,5-二芐氧基苯乙酮
|
21766-81-4
|
|
Terbutaline EP Impurity D
|
特布他林 EP 雜質(zhì) D
|
1797117-23-7
|
|
Prasugrel Impurity O
|
普拉格雷雜質(zhì)O
|
929211-64-3
|
|
Prasugrel Impurity 7
|
普拉格雷雜質(zhì)7
|
1359829-72-3
|
|
2-bromo-1-(3,5-dihydroxyphenyl)ethanone
|
2-溴-3'.5'-二羥基苯乙酮
|
62932-92-7
|
|
Sildenafil Impurity 36
|
西地那非雜質(zhì)36
|
319491-68-4
|
|
Terbutaline Impurity 3
|
特布他林雜質(zhì)3
|
1246815-70-2
|
|
Sildenafil Impurity 37
|
西地那非雜質(zhì)37
|
1027192-92-2
|
|
Descarbon Sildenafil
|
去乙烯基西地那非
|
466684-88-8
|
|
Terbutaline Impurity 27
|
特布他林雜質(zhì)27
|
147942-88-9
|
|
Prasugrel EP Impurity A
|
普拉格雷 EP 雜質(zhì) A
|
1391194-45-8
|
|
Methyl 3,3-difluorocyclobutane-1-carboxylate
|
3,3-二氟環(huán)丁烷甲酸甲酯
|
1234616-13-7
|
|
Prasugrel Impurity 4
|
普拉格雷雜質(zhì)4
|
1618107-96-2
|
|
Prasugrel-d5
|
普拉格雷雜質(zhì)5
|
1127252-92-9
|
|
Prasugrel EP Impurity C
|
普拉格雷 EP 雜質(zhì) C
|
1391194-50-5
|
|
Prasugrel EP Impurity B
|
普拉格雷 EP 雜質(zhì) B
|
1391194-39-0
|
|
Carboplatin Impurity 4
|
卡鉑雜質(zhì)4
|
113287-15-3
|
|
Azithromycin Impurity 18
|
阿奇霉素雜質(zhì)18
|
612069-31-5
|
|
Azithromycin Impurity J
|
阿奇霉素雜質(zhì)J
|
117693-41-1
|
|
Azithromycin Impurity M
|
阿奇霉素雜質(zhì)M
|
765927-71-7
|
|
ErythroMycin A 9,11-IMino Ether
|
紅霉素A 9,11-亞胺醚
|
161193-44-8
|
|
Azithromycin Impurity N
|
阿奇霉素雜質(zhì)N
|
612069-25-7
|
|
Azithromycin Impurity E
|
阿奇霉素雜質(zhì)E
|
612069-27-9
|
|
Norfloxacin Impurity E
|
環(huán)丙沙星雜質(zhì)E
|
105394-83-0
|
|
Azithromycin EP Impurity O
|
阿奇霉素EP雜質(zhì)O
|
763924-54-5
|
|
Ciprofloxacin Impurity 21
|
環(huán)丙沙星雜質(zhì)21
|
105674-91-7
|
|
Ciprofloxacin Impurity 9
|
環(huán)丙沙星雜質(zhì)9
|
1620445-09-1
|
|
Repaglinide Impurity A
|
瑞格列奈雜質(zhì)A
|
220438-80-2
|
|
(S)-Repaglinide Ethyl Ester (Repaglinide IMpurity)
|
(S)-瑞格列奈乙基酯(瑞格列奈雜質(zhì)D）
|
147770-06-7
|
|
Norfloxacin EP Impurity F
|
諾氟沙星EP雜質(zhì)F
|
67681-84-9
|
|
Ciprofloxacin Impurity 7
|
環(huán)丙沙星雜質(zhì)7
|
93594-29-7
|
|
Repaglinide M1 Metabolite
|
瑞格列奈 M1 代謝物
|
874908-11-9
|
|
2-HYDROXY-3''-NITRO-BIPHENYL-3-CARBOXYLIC ACID
|
2'-羥基-3'-硝基-[1,1'-聯(lián)苯]-3-羧酸
|
376591-95-6
|
|
Repaglinide Related CoMpound C
|
瑞格列奈相關(guān)物質(zhì)C
|
107362-12-9
|
|
2-Despiperidyl-2-(5-carboxypentylamine) Repaglinide
|
2-去哌啶基-2-(5-羧基戊胺)瑞格列奈
|
874908-12-0
|
|
5-Chloro-2-hydroxy-3-nitro-(1,1-biphenyl)-3-carboxylic acid
|
5'-氯-3'-硝基-2'-羥基-[1,1'-聯(lián)苯]-3-甲酸
|
376592-58-4
|
|
Repaglinide IMpurity IV
|
瑞格列奈雜質(zhì)IV
|
646054-50-4
|
|
2-Despiperidyl-2-amino Repaglinide
|
2-去哌啶基-2-氨基瑞格列奈
|
637301-29-2
|
|
Ciprofloxacin Impurity 2
|
環(huán)丙沙星雜質(zhì)2
|
528851-30-1
|
|
vildagliptin Impurity P
|
維達列汀雜質(zhì)P
|
1032564-18-3
|
|
R-DoxylaMine
|
R-多西拉敏
|
1391849-33-4
|
|
vildagliptin-d7
|
維格列汀-d7
|
1133208-42-0
|
|
Vildagliptin Impurity 57
|
維格列汀雜質(zhì)57
|
913980-23-1
|
|
DoxylaMine EP IMpurity B
|
多西拉敏EP雜質(zhì)B
|
19490-92-7
|
|
Doxylamine d5
|
多西拉敏d5
|
1216840-94-6
|
|
Doxylamine Impurity 7
|
多西拉敏雜質(zhì)7
|
105176-70-3
|
|
Doxylamine Impurity 5
|
多西拉敏雜質(zhì)5
|
97143-65-2
|
|
Vildagliptin Impurity 9
|
維達列汀雜質(zhì)9
|
2246354-69-6
|
|
vildagliptin Impurity 57
|
維達列汀雜質(zhì)57
|
565452-98-4
|
|
Vildagliptin Related Compound D
|
維格列汀相關(guān)化合物D
|
565453-39-6
|
|
vildagliptin Impurity 73
|
維達列汀雜質(zhì)73
|
1846606-32-3
|
|
Vildagliptin Impurity C
|
維格列汀雜質(zhì)C
|
565453-41-0
|
|
Avanafil Impurity 15
|
阿伐那非雜質(zhì)15
|
2250242-48-7
|
|
Ticagrelor Impurity M
|
替格瑞洛雜質(zhì)M
|
274693-39-9
|
|
Ticagrelor InterMediate 1
|
替卡格雷中間體五元環(huán)
|
274693-55-9
|
|
Ticagrelor Impurity 63
|
替卡格雷雜質(zhì)63
|
2227766-79-0
|
|
Ticagrelor Impurity 81
|
替卡格雷雜質(zhì)81
|
2376278-68-9
|
|
Ticagrelor Impurity N
|
替格瑞洛雜質(zhì)
|
1643378-47-5
|
|
Thiamine EP Impurity H
|
硫胺素EP雜質(zhì)H
|
89285-03-0
|
|
Thiamine Impurity 11
|
鹽酸硫胺素雜質(zhì)11
|
855380-63-1
|
|
Tofacitinib Impurity A
|
托法替布雜質(zhì)A
|
1092578-46-5
|
|
Tofacitinib Impurity 17
|
托法替尼雜質(zhì)17
|
2174011-55-1
|
|
Tofacitinib Impurity D
|
托法替尼雜質(zhì) D
|
384338-23-2
|
|
Tofacitinib Impurity K
|
托法替布雜質(zhì)K
|
2328165-36-0
|
|
Tofacitinib Impurity 34
|
托法替尼雜質(zhì)34
|
1629858-78-1
|
|
Tofacitinib Impurity 42
|
托法替尼雜質(zhì)42
|
2504210-41-5
|
|
Tofacitinib Impurity 15
|
托法替布雜質(zhì)15
|
1092578-48-7
|
|
Thiamine Impurity 10
|
鹽酸硫胺素雜質(zhì)10
|
855380-68-6
|
|
Carbazochrome sodium sulfonate iMpurit 6
|
卡絡(luò)磺鈉雜質(zhì)6
|
130570-60-4
|
|
Lidocaine EP Impurity F
|
利多卡因EP雜質(zhì)F
|
857170-72-0
|
|
Lidocaine EP Impurity K
|
利多卡因EP雜質(zhì)K
|
50295-20-0
|
|
Eltrombopag Impurity 57
|
艾曲波帕雜質(zhì)57
|
893736-72-6
|
|
Eltrombopag Impurity 10
|
艾曲波帕雜質(zhì)10
|
376592-93-7
|
|
Eltrombopag Impurity 6
|
艾曲波帕雜質(zhì)6
|
376592-56-2
|
|
Eltrombopag Impurity 1
|
艾曲波帕雜質(zhì)1
|
1437383-35-1
|
|
Ticagrelor Related Compound 94 HCl
|
替卡格雷相關(guān)化合物94 HCl
|
1643378-59-9
|
|
Ticagrelor Impurity 20
|
替格瑞洛雜質(zhì)20
|
376608-75-2
|
|
Ticagrelor Impurity 2
|
替格瑞洛雜質(zhì)2
|
592533-90-9
|
|
Tofacitinib Impurity 13
|
托法替尼雜質(zhì)13
|
923036-30-0
|
|
Sildenafil Impurity 66
|
西地那非雜質(zhì)66
|
253178-46-0
|
|
Avanafil Impurity 29
|
阿伐那非雜質(zhì)29
|
1364671-52-2
|
|
Avanafil Impurity 12
|
阿伐那非雜質(zhì)12
|
330786-34-0
|
|
Lidocaine EP Impurity J
|
利多卡因EP雜質(zhì)J
|
1012864-23-1
|
|
Lidocaine EP Impurity I
|
利多卡因EP雜質(zhì)I
|
17289-54-2
|
|
Lidocaine Impurity 19
|
利多卡因雜質(zhì) 19
|
1596965-85-3
|
|
Lidocaine Impurity 30
|
利多卡因雜質(zhì)30
|
39084-88-3
|
|
Lidocaine Impurity 27
|
利多卡因雜質(zhì) 27
|
112843-97-7
|
|
Lidocaine Impurity E
|
利多卡因雜質(zhì)E
|
745798-07-6
|
|
4-(3-chloro-4-MethoxybenzylaMino)-5-ethoxycarbonyl-2-MethylsulfinylpyriMidine
|
阿伐那非中間體1
|
330785-82-5
|
|
HydroxythiohoMo Sildenafil
|
羥基硫代高西地那非
|
479073-82-0
|
|
Avanafil Impurity H
|
阿伐那非雜質(zhì)H
|
1638497-26-3
|
|
Mutaprodenafil
|
多丙地那非
|
1387577-30-1
|
|
Sildenafil Impurity 67
|
西地那非雜質(zhì)67
|
358388-58-6
|
|
Sildenafil Impurity 18
|
西地那非雜質(zhì)18
|
2196244-90-1
|
|
Carbazochrome Sodium Sulfonate Impurity 1
|
卡絡(luò)磺鈉雜質(zhì)1
|
13383-73-8
|
|
Carbazochrome Impurity
|
卡絡(luò)磺鈉雜質(zhì)
|
2271443-87-7
|
|
Avanafil Impurity N
|
阿伐那非雜質(zhì)N
|
330785-84-7
|